RioDerm-001 is under clinical development by Rion and currently in Phase II for Diabetic Foot Ulcers.
Pulse Oximeters Once Again in the Spotlight at FDA
Improving the accuracy of pulse oximeters, especially in patients with darker skin pigments, will be the focus at Friday’s meeting of the FDA’s Anesthesiology and